Study Highlights New Target for Antidepressant Therapy
By Sharon Kingman
Wednesday, May 8, 2013
LONDON – The future development of a new class of antidepressants has edged closer, with the discovery of a molecular pathway that is fundamental to the development of depression.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.